Author Archives: Health

FDA Approves Lorbrena (lorlatinib) for Previously-Treated ALK-Positive Metastatic Non-Small Cell Lung Cancer

FDA Approves Lorbrena (lorlatinib) for Previously-Treated ALK-Positive Metastatic Non-Small Cell Lung Cancer Print this page November 2, 2018 Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved Lorbrena [lor-BREN-ah] (lorlatinib), a third-generation anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor (TKI) for patients with ALK-positive metastatic non-small cell lung cancer… Read More »

Prolonged HIV suppression is possible using ibalizumab, analysis of highly drug-resistant patients shows

A treatment regimen containing ibalizumab (Trogarzo), a monoclonal antibody designed to block HIV, led to substantial viral load reductions in a majority of highly treatment-experienced people with few treatment options left, Dr Zvi Cohen of Theratechnologies reported at the International Congress on Drug Therapy in HIV Infection (HIV Glasgow) on Wednesday. Fifteen out of 40… Read More »

NIH boosts BRAIN Initiative funding to expand study into opioids

The National Institutes of Health is making new investments into the BRAIN Initiative, which will include new studies of opioids. New funds of $ 220 million to support 200 new research awards have been awarded, bringing total 2018 program support to more than $ 400 million, which is 50 percent more than the amount spent… Read More »

Healthcare price growth significantly outpaces inflation

Healthcare prices continue to rise across the country, according to a new study. Over a five-year period, healthcare prices increased in 111 out of 112 metro areas analyzed by the Health Care Cost Institute. The outlier was Durham-Chapel Hill, N.C., where prices dropped 5% from 2012 to 2016, HCCI’s analysis of 1.78 billion commercial health… Read More »